Sort
172,184 grants matching “inflammation”
Clinical Risk Factors for Primary Graft Dysfunction
$915,565Jason D Christie · University Of Pennsylvania · R01 · FY2014 · HL
Viral Vector Core
$915,523Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIC · FY2016 · ES
Functional Significance of Mutations in Helicase Genes in Patients with Juvenile Dermatomyositis and anti-MDA5 Autoantibodies
$915,332Robert Brosh · National Institute On Aging · ZIA · FY2024 · AG
ULTIMATE
$915,292Reinout Van Crevel · Stichting Radboud Universiteit · R01 · FY2019 · AI
Gene Expression for Functional Genomics in Human Populations
$915,265Christopher O'Donnell · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Light, metabolic syndrome and Alzheimer's disease: a non-pharmacological approach
$915,187Mariana Gross Figueiro · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AG
Transfusion-Related Acute Lung Injury: Incidence and Mechanisms
$915,052Pearl T Toy · University Of California, San Francisco · P50 · FY2008 · HL
Epigenetic control during embryogenesis
$915,001Kathrin Muegge · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Enabling Studies for the Treatment of Frozen Shoulder Using Relaxin
$914,843Benjamin Goldman Cooper · Ortholevo, Inc. · R44 · FY2022 · AR
ANCA GLOMERULONEPHRITIS: FROM MOLECULES TO MAN
$914,708University Of North Carolina Chapel Hill · P01 · FY2005 · DK
Measuring cellular senescence to predict and prevent peripheral neuropathy
$914,673Natalia Mitin · Sapere Bio, Inc. · R44 · FY2021 · AG
A Novel Immunological-Directed Live Biotherapy Product for Treating Ulcerative Colitis
$914,660Gary Fanger · Rise Therapeutics, Llc · R44 · FY2024 · DK
Pre- and Peri-natal Predictors of Childhood Obesity
$914,581Emily Oken · Harvard Pilgrim Health Care, Inc. · R01 · FY2016 · HD
A smart cell drug (SmaCD) delivery platform for mobile, targetable, and self-regulated combination therapy: a model project to rescue antibodies from Alzheimer's disease (AD) clinical trial failures
$914,477Julie Kay Andersen · Buck Institute For Research On Aging · R01 · FY2025 · AG
Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure
$914,341Kory J. Lavine · Washington University · R35 · FY2024 · HL
A Bioresorbable Subdermal Implant for Sustained Delivery of a Novel Maturation Inhibitor to Prevent HIV Infection
$914,204John A Moss · Oak Crest Institute Of Science · R01 · FY2020 · AI
Core E: Proteomics Core
$914,094Richard D Smith · Massachusetts General Hospital · U54 · FY2010 · GM
Clinical, genetic and cardiometabolic risk correlates of the gut microbiome
$914,048Stanley Y Shaw · Broad Institute, Inc. · R01 · FY2016 · HL
Significance of Microenvironment for Prostate Cancer Initiation and Progression
$913,934Stephen R Plymate · University Of Washington · U54 · FY2009 · CA
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer
$913,866Mary Christine Playdon · University Of Utah · U01 · FY2022 · CA
HARNESSING HOST RESPONSE TO PREVENT MYELOMA
$913,781Madhav V Dhodapkar · Emory University · R35 · FY2022 · CA
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
$913,659Bill Thelin · Altis Biosystems, Inc. · R44 · FY2023 · TR
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
$913,659Christopher Eldridge Sims · Altis Biosystems, Inc. · R44 · FY2024 · TR
Basic and Clinical Studies of Cystic Fibrosis
$913,492Raymond A Frizzell · University Of Pittsburgh At Pittsburgh · P30 · FY2013 · DK
Therapeutic to Reduce Acute Inflammation in Severe Burn Injuries
$913,491Elisabeth M Alicot-Carroll · Decimmune Therapeutics, Inc · R44 · FY2010 · GM